ILMN

Illumina, Inc. · Healthcare · Medical - Diagnostics & Research
$130.32
+3.36 (+2.65%)
Mkt Cap: 19.93B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield4.5%
Dividend YieldN/A
Market Cap19.93B
Volume1.19M
Recent News
Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease
prnewswire.com · 2026-04-14
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
zacks.com · 2026-04-13
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report?
zacks.com · 2026-04-10
Douglas Lane & Associates LLC Purchases 26,014 Shares of Illumina, Inc. $ILMN
defenseworld.net · 2026-04-10
Illumina: Competitive Threats Priced In
seekingalpha.com · 2026-04-10
Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026
prnewswire.com · 2026-04-09

Unlock the Full Deep Scan

9 AI agents analyze ILMN across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →